Artiva Biotherapeutics Inc Share Price

NASDAQ: ARTV

Small Cap

$2.34

-0.01

(-0.43%)

as on September 17, 2025 at 1:29 am IST

$₹

Artiva Biotherapeutics Inc Stock Performance

as on September 17, 2025 at 1:29 am IST

Day's Low
Day's High
$2.3
Day's Price Range
$2.5
$2.34
1.71%
Downside
6.84%
Upside
52 Week's Low
52 Week's High
$1.47
52-Week Price Range
$17.31
$2.34
37.18%
Downside
639.74%
Upside

Artiva Biotherapeutics Inc share price movements today

Previous Close: $2.35
Open: $2.50
Volume: 165.1K
Day's Low - High: $2.3 - $2.5
52 Week Low - High: $1.47 - $17.31

Artiva Biotherapeutics Inc Historical Returns

1 Month Return: -13.82 %
3 Month Return: + 31.67 %
1 Year Return: -78.36 %
3 Year Return: 0 %
5 Year Return: 0 %

Artiva Biotherapeutics Inc Stock Fundamentals & Key Indicators

Check Artiva Biotherapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$62.3M

EPS (TTM)

-3.13

Dividend Yield

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

Return On Equity TTM

858100.00%

Artiva Biotherapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Artiva Biotherapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Artiva Biotherapeutics Inc	NA	$62.3M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	252.04%	-505.15	-12.96%
Beone Medicines Ltd	NA	$39.0B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$100.3B	44.17%	27.85	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	1.78%	14.1	31.37%

Stock Returns calculator for Artiva Biotherapeutics Inc Stock including INR - Dollar returns

The Artiva Biotherapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Artiva Biotherapeutics Inc investment value today

Current value as on today

₹25,968

Returns

₹74,032

(-74.03%)

Returns from Artiva Biotherapeutics Inc Stock

₹78,630 (-78.63%)

Dollar Returns*

₹4,598 (+4.6%)

Artiva Biotherapeutics Inc Stock's Interest Amongst Investors

Search interest for Artiva Biotherapeutics Inc Stock has decreased by -22% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 18, 2025 to September 17, 2025

Change:-22% versus previous 30 day period

Artiva Biotherapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	0	-	26	2	0	-	-	-	-	-
Gross Profit	0	-	26	2	0	-	-	-	-	-
Operating Income	-17	-11	10	-11	-14	-16	-18	-18	-22	-22
EBITDA	-17	-14	11	-11	-13	-15	-17	-17	-21	-22
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-16	-15	11	-10	-13	-14	-17	-9	-20	-21
Income Tax Expense	-1	0	-	0	0	-1	-	-	-	-
Net Income	-16	-15	11	-10	-13	-14	-17	-9	-20	-21
Net Profit Margin	-1690.29%	0.00%	42.31%	-466.98%	-5562.95%	0.00%	0.00%	0.00%	0.00%	0.00%

Artiva Biotherapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	2	4	33	0
Gross Profit	-	2	4	33	0
Operating Income	-18	-53	-59	-30	-67
EBITDA	-17	-71	-58	-28	-64
Interest Expense	0	-	-	-	-
Depreciation	0	0	1	2	2
Income Before Tax	-17	-71	-58	-27	-58
Income Tax Expense	0	-18	0	0	-
Net Income	-17	-71	-58	-27	-58
Net Profit Margin	0.00%	-3587.66%	-1184.10%	-82.69%	-23303.98%

Artiva Biotherapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-11	11	-11	-13	-17	-17	-16	-20	-21
Operating Cash Flow	-11	-10	-10	-15	-13	-11	-14	-19	-22
Investing Cash Flow	-20	0	-2	9	1	-130	0	9	21
Financing Cash Flow	0	23	0	-	-1	163	0	0	0
Change in Cash	-32	12	-12	-5	-13	21	-15	-9	-1

Artiva Biotherapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-71	-58	-28	-65
Operating Cash Flow	-15	-50	-47	-55
Investing Cash Flow	-1	-6	-25	-120
Financing Cash Flow	152	-1	24	162
Change in Cash	135	-58	-49	-13

Insights on Artiva Biotherapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.1% return, outperforming this stock by 146.5%
NEGATIVE IMPACT
Price Dip
In the last 7 days, ARTV stock has moved down by -12.2%

About Artiva Biotherapeutics Inc

Artiva Biotherapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on developing natural killer (NK) cell-based therapies for patients suffering from devastating autoimmune diseases and cancers. Its product candidates are derived from donor cells (allogeneic) rather than a patient's own cells (autologous) and are pre-manufactured, stored frozen and ready to ship to a patient's treatment location. Its lead product candidate, AlloNK, is being evaluated in combination with B-cell targeted monoclonal antibodies (mAbs) in patients with autoimmune diseases and cancers, such as systemic lupus erythematosus (SLE), lupus nephritis (LN), RA, PV, the ANCA-associated vasculitis subtypes GPA/MPA, and B-NHL. AlloNK is a non-genetically modified, cryopreserved NK cell therapy being evaluated in combination with B-cell targeted mAbs in an ongoing Phase I/Ib trial in SLE with or without LN and a basket investigator-initiated trial (IIT) in multiple autoimmune indications.

Organisation	Artiva Biotherapeutics Inc
Headquarters	5505 Morehouse Drive, San Diego, CA, United States, 92121
CEO	Dr. Fred Aslan M.D.
E-voting on shares	Click here to vote

Key Management of Artiva Biotherapeutics Inc

Name	Title
Dr. David Moriarty Ph.D.	Senior VP of Clinical Operations
Dr. Subhashis Banerjee M.D.	Chief Medical Officer
Ms. Neha Krishnamohan	CFO & Executive VP of Corporate Development
Ms. Jennifer Kinsbruner Bush Esq., J.D.	Executive VP, COO, Chief Legal Officer, Corporate Secretary & Compliance Officer
Dr. Peter Flynn Ph.D.	Co-Founder & Strategic Advisor
Mr. Christopher P. Horan	Chief Technical Operations Officer
Dr. Fred Aslan M.D.	President, CEO & Director
Dr. Heather Raymon Ph.D.	Senior Vice President of Research & Early Development
Mr. Benjamin Dewees	Senior Vice President of Regulatory Affairs
Mr. Feng Xu	Senior Vice President of Biometrics

FAQs

What is Artiva Biotherapeutics Inc share price today?

Artiva Biotherapeutics Inc share price today is $2.34 as on September 17, 2025 at 1:29 am IST at the close of the market. Artiva Biotherapeutics Inc share today touched a day high of $2.5 and a low of $2.3.

What is the 52 week high and 52 week low for Artiva Biotherapeutics Inc share?

Artiva Biotherapeutics Inc share touched a 52 week high of $17.31 on October 1, 2024 and a 52 week low of $1.47 on June 27, 2025. Artiva Biotherapeutics Inc stock price today i.e. September 17, 2025 at 1:29 am IST is closed at $2.34,which is 86.48% down from its 52 week high and 59.18% up from its 52 week low.

What is Artiva Biotherapeutics Inc's market capitalisation today?

Artiva Biotherapeutics Inc market capitalisation is $0.00T as on September 17, 2025 at 1:29 am IST.

How to invest in Artiva Biotherapeutics Inc Stock (ARTV) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Artiva Biotherapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Artiva Biotherapeutics Inc Shares that will get you 0.6410 shares as per Artiva Biotherapeutics Inc share price of $2.34 per share as on September 17, 2025 at 1:29 am IST.

What is the minimum amount required to buy Artiva Biotherapeutics Inc Stock (ARTV) from India?

Indian investors can start investing in Artiva Biotherapeutics Inc (ARTV) shares with as little as ₹87.816 or $1 (as of September 17, 2025 at 6:41 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Artiva Biotherapeutics Inc stock (as per the Rupee-Dollar exchange rate as on September 17, 2025 at 6:41 pm IST). Based on Artiva Biotherapeutics Inc share’s latest price of $2.34 as on September 17, 2025 at 1:29 am IST, you will get 4.2735 shares of Artiva Biotherapeutics Inc. Learn more about fractional shares .